Cargando…
Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid
In cystic fibrosis (CF) therapy, the recent approval of CF-transmembrane conductance regulator (CFTR) channel modulators is considered to be the major breakthrough. However, the current first-line approach based mainly on pulmonary function to measure effects of the novel therapy, tested by forced e...
Autores principales: | Mainz, Jochen G., Arnold, Christin, Wittstock, Kara, Hipler, Uta-Christina, Lehmann, Thomas, Zagoya, Carlos, Duckstein, Franziska, Ellemunter, Helmut, Hentschel, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131546/ https://www.ncbi.nlm.nih.gov/pubmed/34025651 http://dx.doi.org/10.3389/fimmu.2021.642180 |
Ejemplares similares
-
Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage
por: Erdmann, Nina, et al.
Publicado: (2022) -
Would it have happened without Christmas? Thoracic emphysema and allergic bronchopulmonary aspergillosis in a juvenile cystic fibrosis patient with the G551D mutation receiving ivacaftor
por: Mainz, Jochen G., et al.
Publicado: (2021) -
EPS4.7 Cytokine dynamics in upper airway epithelial lining fluid of CF patients in relation to the status of colonization with Pseudomonas aeruginosa
por: Jaudszus, A., et al.
Publicado: (2017) -
Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy
por: Müller, Ulrike, et al.
Publicado: (2015) -
Evaluation of the upper airway microbiome and immune response with nasal epithelial lining fluid absorption and nasal washes
por: Shilts, Meghan H., et al.
Publicado: (2020)